Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD [Phase 4]
A Phase 4 clinical trial update evaluating the effectiveness of guideline-indicated antiplatelet therapy for acute coronary syndrome in pati…
-
CLINICAL_TRIALS research · 2018-05-14Clinical Trial Update: Impact of Text Messages to Promote Secondary Prevention After Acute Coronary Syndrome [NA]
A clinical trial update evaluating whether text messages can improve secondary prevention after acute coronary syndrome. Sponsored by the Fe…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity [Phase 2, Phase 3]
A clinical trial update discusses a Phase 2/3 study evaluating half-dose ticagrelor versus high-dose clopidogrel in acute coronary syndrome …
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Hormones Inflammation and Thrombosis [Phase 4]
A Phase 4 clinical trial sponsored by Johns Hopkins University evaluating a hormone/inflammation/thrombosis approach in acute coronary syndr…
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Polyprenols (Ropren) in Acute Coronary Syndrome [Phase 3]
Phase 3 trial evaluating polyprenols (Ropren) in acute coronary syndrome has completed; results are not provided in this update.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study) [Phase 4]
A Phase 4 study evaluating thrombelastography-guided antiplatelet therapy in acute coronary syndromes was terminated, with results posted in…
-
CLINICAL_TRIALS research · 2018-04-25Clinical Trial Update: Randomized "All-comer" Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent [Phase 4]
Phase 4 randomized trial comparing the Resolute Integrity permanent-polymer stent with a polymer-free Cre8 stent in patients with stable ang…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach. [Phase 1, Phase 2]
Phase 1/2 trial assessing the safety and tolerability of sodium thiosulfate in patients with acute coronary syndrome undergoing coronary ang…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome [NA]
A completed clinical trial update evaluating platelet reactivity after a ticagrelor loading dose and tracking outcomes over one year in acut…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Interest of CARE Rule to Exclude the Hypothesis of an Acute Coronary Syndrome Without Bioassay - ICARE
The ICARE trial evaluating the CARE Rule to exclude acute coronary syndrome without a bioassay in patients with chest pain has completed.
-
CLINICAL_TRIALS withdrawal · 2018-04-04Clinical Trial Update: Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis [Phase 4]
A Phase 4 trial comparing the pharmacodynamics of ticagrelor and clopidogrel after thrombolysis in patients with acute coronary syndromes wa…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel
A completed clinical trial compared ticagrelor against a very low-dose rivaroxaban regimen with clopidogrel in patients with Acute Coronary …
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Mechanisms of Social Inequalities in Post-hospitalization Rehabilitation in Patients With Acute Coronary Syndrome
This clinical trial update indicates the study on mechanisms of social inequalities in post-hospitalization rehabilitation for patients with…
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: IMproving reModeling in Acute myoCardial Infarction Using Live and Asynchronous TElemedicine. [NA]
Clinical trial update from Singapore investigates improving remodeling after acute myocardial infarction using live and asynchronous telemed…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: AngelMed for Early Recognition and Treatment of STEMI [Phase 3]
Phase 3 trial update for the AngelMed Guardian System targeting STEMI, with the study status shown as completed.
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients
This clinical trial update reports safety findings for ticagrelor in Chinese patients with Acute Coronary Syndrome. The study NCT02430493 ha…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Ethnic Differences in Acute Coronary Syndromes Care in Emergency Departments.
This completed clinical trial from the University of British Columbia investigates ethnic differences in the treatment of acute coronary syn…
-
CLINICAL_TRIALS withdrawal · 2018-03-13Clinical Trial Update: Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention [Phase 3]
Phase 3 trial of Aggrastat (tirofiban) in patients undergoing percutaneous coronary intervention for myocardial infarction or acute coronary…
-
FDA approval · 2018-03-09FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Brilinta (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2018-03-09FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2018-03-07FDA Approved: EPTIFIBATIDE — Original Application (Sagent Pharmaceuticals)
FDA approved EPTIFIBATIDE from Sagent Pharmaceuticals via an Original Application, marking regulatory approval for this product.
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Stent Thrombosis In Acute Coronary Syndromes
A clinical trial evaluating stent thrombosis in the setting of acute coronary syndrome has completed. It was sponsored by the University of …
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy [Phase 4]
Phase 4 trial updating on aspirin's impact on platelet reactivity in acute coronary syndrome patients receiving novel P2Y12 inhibitors.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia. [Phase 4]
Phase 4 trial comparing MEOPA + paracetamol versus morphine for analgesia in acute coronary syndrome has completed.
-
FDA approval · 2018-02-02FDA Approved: PRASUGREL — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s original ANDA for a generic prasugrel product, expanding access to this antiplatelet therapy used …